NCS Multistage Q2 net loss $4.6M vs $0.9M income YoY; revenue up 5% to $38.4M

NCS Multistage Holdings, Inc.

Net loss per share $(1.71) vs diluted EPS $0.34 in Q2 2025; adjusted EBITDA $1.9M vs $2.2M.
Total revenues $38.4M (+5% YoY) driven by Repeat Precision and U.S. tracer diagnostics.
Cash $31.3M, total debt $7.5M (finance leases); ABL facility undrawn with $14.5M borrowing base.
Pending combination with Weatherford noted; professional fees increased due to strategic activities.
ResMetrics acquisition (July 2025) contributed $2.3M services revenue in Q2 2026.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.